Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome

Journal of the American College of Nutrition

Volumn 29, Issue 1, 2010, Pages 31-40

  Basu, Arpita ^a   Sanchez, Karah ^a   Leyva, Misti J ^a   Wu, Mingyuan ^b   Betts, Nancy M ^a   Aston, Christopher E ^a   Lyons, Timothy J ^a,b  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYNONENAL; DRINKING WATER; EPICATECHIN; EPICATECHIN GALLATE; EPIGALLOCATECHIN; EPIGALLOCATECHIN GALLATE; GLUCOSE; GREEN TEA EXTRACT; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; MYELOPEROXIDASE; OXIDIZED LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DRUG BIOAVAILABILITY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; LIPID PEROXIDATION; MALE; METABOLIC SYNDROME X; NUCLEAR MAGNETIC RESONANCE IMAGING; OBESITY; OXIDATIVE STRESS; PARTICLE SIZE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE;

ADULT; ALDEHYDES; BIOLOGICAL AVAILABILITY; BODY MASS INDEX; BODY WEIGHT; CAMELLIA SINENSIS; CASE-CONTROL STUDIES; CATECHIN; CHOLESTEROL; FEMALE; HUMANS; HYPOLIPIDEMIC AGENTS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; METABOLIC SYNDROME X; OBESITY; PATIENT COMPLIANCE; PHYTOTHERAPY; PLANT EXTRACTS; SINGLE-BLIND METHOD;

EID: 77956543364     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2010.10719814     Document Type: Article

References (47)

1. Widlansky ME, Hamburg NM, Anter E, Holbrook M, Kahn DF, Elliott JG, Keaney JF Jr, Vita JA: Acute EGCG supplementation reverses endothelial dysfunction in patients with coronary artery disease. J Am Coll Nutr 26:95–102, 2007.
2. Basu A, Lucas EA: Mechanisms and effects of green tea on cardiovascular health. Nutr Rev 65:361–375, 2007.
3. Venables MC, Hulston CJ, Cox HR, Jeukendrup AE: Green tea extract ingestion, fat oxidation, and glucose tolerance in healthy humans. Am J Clin Nutr 87:778–784, 2008.
4. Cabrera C, Artacho R, Giménez R: Beneficial effects of green tea-a review. J Am Coll Nutr 25:79-99, 2006.
5. Kuriyama S, Shimazu T, Ohmori K, Kikuchi N, Nakaya N, Nishino Y, Tsubono Y, Tsuji I: Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA 296:1255-1265, 2006.
6. Yang YC, Lai FH, Wu JS, Wu CH, Chang CJ: The protective effect of habitual tea consumption on hypertension. Arch Intern Med 164:1534-1540, 2004.
7. Sano J, Inami S, Seimiya K, Ohba T, Sakai S, Takano T, Mizuno K: Effects of green tea intake on the development of coronary artery disease. Cire J 68:665-670, 2004.
8. Sasazuki S, Kodama H, Yoshimasu K, Liu Y, Washio M, Tanaka K, Tokunaga S, Kono S, Arai H, Doi Y, Kawano T, Nakagaki O, Takada K, Koyanagi S, Hiyamuta K, Nii T, Shirai K, Ideishi M, Arakawa K, Mohri M, Takeshita A: Relation between green tea consumption and the severity of coronary atherosclerosis among Japanese men and women. Ann Epidemiol 10:401-408, 2000.
9. Yokozawa T, Nakagawa T, Kitani K: Antioxidative activity of green tea polyphenol in cholesterol-fed rats. J Agrie Food Chem 50:3549-3552, 2002.
10. Choi JH, Chai YM, Joo GJ, Rhee IK, Lee IS, Kim KR, Choi MS, Rhee SJ: Effects of green tea catechin on polymorphonuclear leukocyte 5'-lipoxygenase activity, leukotriene B4 synthesis, and renal damage in diabetic rats. Ann Nutr Metab 48:151-155, 2004.
11. Locher R, Emmanuele L, Suter PM, Vetter W, Barton M: Green tea polyphenols inhibit human vascular smooth muscle cell proliferation stimulated by native low-density lipoprotein. Eur J Pharmacol 434:1-7, 2002.
12. Raederstorff DG, Schlachter MF, Eiste V, Weber P: Effect of EGCG on lipid absorption and plasma lipid levels in rats. J Nutr Biochem 14:326-332, 2003.
13. Yang TT, Koo MW: Chinese green tea lowers cholesterol level through an increase in fecal lipid excretion. Life Sei 66:411-423, 2000.
14. Babu PV, Sabitha KE, Srinivasan P, Shyamaladevi CS: Green tea attenuates diabetes induced Maillard-type fluorescence and collagen cross-linking in the heart of streptozotocin diabetic rats. Pharmacol Res 55:433-440, 2007.
15. Chyu KY, Babbidge SM, Zhao X, Dandillaya R, Rietveld AG, Yano J, Dimayuga P, Cercek B, Shah PK: Differential effects of green tea-derived catechin on developing versus established atherosclerosis in apolipoprotein E-null mice. Circulation 109:2448-2453, 2004.
16. Negishi H, Xu JW, Ikeda K, Njelekela M, Nara Y, Yamori Y: Black and green tea polyphenols attenuate blood pressure increases in stroke-prone spontaneously hypertensive rats. J Nutr 134:38-42, 2004.
17. Klaunig JE, Xu Y, Han C, Kamendulis LM, Chen J, Heiser C, Gordon MS, Mohler ER 3rd: The effect of tea consumption on oxidative stress in smokers and nonsmokers. Proc Soc Exp Biol Med 220:249-254, 1999.
18. Lee W, Min WK, Chun S, Lee YW, Park H, Lee DH, Lee YK, Son JE: Long-term effects of green tea ingestion on atherosclerotic biological markers in smokers. Clin Biochem 38:84-87, 2005.
19. Coimbra S, Castro E, Rocha-Pereira P, Rebelo I, Rocha S, Santos-Silva A: The effect of green tea in oxidative stress. Clin Nutr 25:790-796, 2006.
20. Tinahones FJ, Rubio MA, Garrido-Sánchez L, Ruiz C, Gordillo E, Cabrerizo L, Cardona F: Green tea reduces LDL oxidability and improves vascular function. J Am Coll Nutr 27:209-213, 2008.
21. Freese R, Basu S, Hietanen E, Nair J, Nakachi K, Bartsch H, Mutanen M: Green tea extract decreases plasma malondialdehyde concentration but does not affect other indicators of oxidative stress, nitric oxide production, or hemostatic factors during a high-linoleic acid diet in healthy females. Eur J Nutr 38:149-157, 1999.
22. Fukino Y, Shimbo M, Aoki N, Okubo T, Iso H: Randomized controlled trial for an effect of green tea consumption on insulin resistance and inflammation markers. J Nutr Sei Vitaminol (Tokyo) 51:335-342, 2005.
23. Fukino Y, Ikeda A, Maruyama K, Aoki N, Okubo T, Iso H: Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr 62:953-960, 2008.
24. Ramos RG, Olden K: The prevalence of metabolic syndrome among US women of childbearing age. Am J Public Health 98:1122-1127, 2008.
25. Beydoun MA, Wang Y: Gender-ethnic disparity in BMI and waist circumference distribution shifts in US adults. Obesity 17:169-176, 2009.
26. Pillitteri JL, Shiftman S, Rohay JM, Harkins AM, Burton SL, Wadden TA: Use of dietary supplements for weight loss in the United States: results of a national survey. Obesity 16:790-796, 2008.
27. Grundy SM: Metabolic syndrome: a multiplex cardiovascular risk factor. J Clin Endocrinol Metab 92:399-404, 2007.
28. Roberts CK, Won D, Pruthi S, Kurtovic S, Sindhu RK, Vaziri ND, Barnard RJ: Effect of a short-term diet and exercise intervention on oxidative stress, inflammation, MMP-9, and monocyte chemotactic activity in men with metabolic syndrome factors. J Appl Physiol 100:1657-1665, 2006.
29. Westerterp-Plantenga MS, Lejeune MP, Kovacs EM: Body weight loss and weight maintenance in relation to habitual caffeine intake and green tea supplementation. Obes Res 13:1195-1204, 2005.
30. Kovacs EM, Lejeune MP, Nijs I, Westerterp-Plantenga MS: Effects of green tea on weight maintenance after body-weight loss. BrJ Nutr 91:431-437, 2004.
31. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC Jr, Spertus JA, Costa F, American Heart Association; National Heart, Lung, and Blood Institute: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112:2735-2752, 2005.
32. Seeram NP, Henning SM, Niu Y, Lee R, Scheuller HS, Heber D: Catechin and caffeine content of green tea dietary supplements and correlation with antioxidant capacity. J Agrie Food Chem 54:1599-1603, 2006.
33. Masukawa Y, Matsui Y, Shimizu N, Kondou N, Endou H, Kuzukawa M, Hase T: Determination of green tea catechins in human plasma using liquid chromatography-electrospray ionization mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sei 834:26-34, 2006.
34. Lyoas TJ, Jenkins AJ, Zheng D, Klein RL, Otvos JD, Yu Y, Lackland DT, McGee D, McHenry MB, Lopes-Virella M, Garvey WT, DCCT/EDIC Research Group: Nuclear magnetic resonance-rmined lipoprotein subclass profile in the DCCT/EDIC cohort: associations with carotid intima-media thickness. Diabet Med 23:955-966, 2006.
35. Nagao T, Komine Y, Soga S, Meguro S, Hase T, Tanaka Y, Tokimitsu I: Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr 81:122-129, 2005.
36. Nagao T, Hase T, Tokimitsu I: A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity 15:1473-1483, 2007.
37. Auvichayapat P, Prapochanung M, Tunkamnerdthai O, Sripanid-kulchai BO, Auvichayapat N, Thinkhamrop B, Kunhasura S, Wongpratoom S, Sinawat S, Hongprapas P: Effectiveness of green tea on weight reduction in obese Thais: a randomized, controlled trial. Physiol Behav 93:486-491, 2008.
38. Hill AM, Coates AM, Buckley JD, Ross R, Thielecke F, Howe PR: Can EGCG reduce abdominal fat in obese subjects? J Am Coll Nutr 26:396S-402S, 2007.
39. Maki KC, Reeves MS, Farmer M, Yasunaga K, Matsuo N, Katsuragi Y, Komikado M, Tokimitsu I, Wilder D, Jones F, Blumberg JB, Cartwright Y: Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J Nutr 139:264-270, 2009.
40. Wolfram S, Wang Y, Thielecke F: Anti-obesity effects of green tea: from bedside to bench. Mol Nutr Food Res 50:176-187, 2006.
41. Lee MJ, Maliakal P, Chen L, Meng X, Bondoc FY, Prabhu S, Lambert G, Mohr S, Yang CS: Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol Biomarkers Prev 11:1025-1032, 2002.
42. Henning SM, Niu Y, Lee NH, Thames GD, Minutti RR, Wang H, Go VL, Heber D: Bioavailability and antioxidant activity of tea flavanols after consumption of green tea, black tea, or a green tea extract supplement Am J Clin Nutr 80:1558-1564, 2004.
43. Chow HH, Hakim IA, Vining DR, Crowell JA, Ranger-Moore J, Chew WM, Celaya CA, Rodney SR, Hara Y, Alberts DS: Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals. Clin Cancer Res 11:4627-4633, 2005.
44. Institute of Medicine: “Dietary Reference Intakes: The Essential Guide to Nutrient Requirements.” Washington, DC: National Academies Press, 2006.
45. National Center for Chronic Disease Prevention & Health Promotion. Behavioral Risk Factor Surveillance System. Accessed at: http://apps.nccd.cdc.gov/BRFSS/display.asp?yr= 2007&cat= FV &qkey=4415&state= OK.
46. Maras JE, Bermudez OI, Qiao N, Bakun PJ, Boody-Alter EL, Tucker KL: Intake of alpha-tocopherol is limited among US adults. J Am Diet Assoc 104:567-575, 2004.
47. Reedy J, Krebs-Smith SM: A comparison of food-based recommendations and nutrient values of three food guides: USDA’s MyPyramid, NHLBI’s Dietary Approaches to Stop Hypertension Eating Plan, and Harvard’s Healthy Eating Pyramid. J Am Diet Assoc 108:522-528, 2008.